Matthew L. Posard Insider Trading $DMTK DermTech, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew L. Posard.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew L. Posard. Matthew L. Posard is Sr VP & General Manager in ILLUMINA INC ($ILMN) and Sr VP & GM, Consumer Genomics in ILLUMINA INC ($ILMN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Commercial Officer in Trovagene, Inc. ($XNOM.OB) and Director in Talis Biomedical Corp ($TLIS) and Director in DermTech, Inc. ($DMTK).

Matthew L. Posard in DermTech, Inc.

Trading Symbol: DMTK
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Matthew L. Posard: Director
Holdings: 86,863 shares
Latest Transaction: Jan 13 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Matthew L. Posard in DermTech, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, XNOM.OB, DMTK, GYHT, ILMN, TLIS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 13 2021DMTKDermTech, Inc.Posard Matthew L.DirectorBuyP29.5033,898999,99186,86353 K to 86.9 K (+64.00 %)
Jun 19 2020DMTKDermTech, Inc.Posard Matthew L.DirectorGrantA0.008,000052,96545 K to 53 K (+17.79 %)
May 01 2020DMTKDermTech, Inc.Posard Matthew L.DirectorOption ExerciseM6.949,70267,3320
May 01 2020DMTKDermTech, Inc.Posard Matthew L.DirectorBuyM6.949,70267,33244,96535.3 K to 45 K (+27.51 %)

Page:   1